Methods and formulations for improved bioavalability of antiprogestins

Details for Australian Patent Application No. 2007339820 (hide)

Owner Repros Therapeutics Inc.

Inventors Podolski, Joseph

Agent Davies Collison Cave

Pub. Number AU-A-2007339820

PCT Pub. Number WO2008/083192

Priority 60/885,372 17.01.07 US; 60/882,423 28.12.06 US

Filing date 27 December 2007

Wipo publication date 10 July 2008

International Classifications

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/083192 Priority application(s): WO2008/083192

20 August 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Methods and formulations for improved bioavailability of antiprogestins 2008

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007339839-Information-retrieval systems, methods, and software with concept-based searching and ranking

2007339810-An apparatus for producing a stable oxidizing biocide